HIMS
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINEHims & Hers Health, Inc. Class A Common Stock (HIMS) [ST]
www.forhims.com ↗▼ 0.27%
prev close
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
+1
1 buys · 0 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-08-04 | HIMSHims & Hers Health, Inc. Class A Common Stock | Buy | $1,001 - $15,000 | 313d ago | — |
2025-08-04
Lisa McClain
HIMS
Amount
$1,001 - $15,000
Filed
313d ago
Recent News
Powered by Polygon.io
Lowey Dannenberg, P.C. Investigates Hims & Hers Health, Inc. for Alleged Tracking of User Data
Hims & Hers Pullback Could Create a Better Entry Into GLP-1 Demand
Is Hims & Hers Stock an Undervalued Stock to Buy?
Hims & Hers Debt-Funded Expansion Tests Its Global Telehealth Ambitions
Hims & Hers Massive Stock Drop Explained
Trade Timeline
Congressional activity, newest first
Lisa McClain
2025-08-04 · Purchase
$1,001 - $15,000